logo
A Mysterious Light in the Sky Seemed to Be a UFO — Here's What It Really Was

A Mysterious Light in the Sky Seemed to Be a UFO — Here's What It Really Was

Yahoo12 hours ago
The strange white light appeared above the sky in upstate New York on the evening of Aug. 12
NEED TO KNOW
People in upstate New York observed an unusual white light that they thought was a UFO in the night's sky on Aug. 12
The light was from the tail and plume of the Vulcan Centaur rocket, which launched from Florida
The spacecraft is designed to provide data similar to that of a GPS system and will test a variety of new technologies
Residents of upstate New York were recently met with an unusual sight — a bright white light in the night sky with a strange-looking aura.
The mysterious light appeared the evening of Tuesday, Aug. 12, per local news outlet the Times Union.
A number of area residents posted about the sighting on social media, with several speculating it might be a UFO, according to the New York Post.
https://people-app.onelink.me/HNIa/kz7l4cuf
However, it turns out that the source of the light had a much more earthly explanation: Local residents were observing the tail and plume of the Vulcan Centaur rocket, which was launched on Aug. 12 from the Cape Canaveral Space Force Station in Florida at around 9 p.m. local time, per Space.com.
The rocket carried an experimental navigation satellite and was launched by the United Launch Alliance (ULA) on behalf of the U.S. military, per the outlet. It launched with four side-mounted rocket boosters in order to send the satellite directly into geosynchronous orbit.
Additionally, it was the U.S. military's first experimental navigation satellite to be launched in 48 years, per Space.com. The spacecraft is designed to provide data similar to that of a GPS system and will test a variety of new technologies.
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer​​, from celebrity news to compelling human interest stories.
This was the Vulcan's third successful flight. The 202-foot rocket took flight in January 2024 and again in October of the same year.
The most recent launch marked one of ULA's longest flights ever, at seven hours and 22,000 miles, according to the ULA blog.
Upstate New York residents were looking up at the sky for good reason the night of the launch: It coincided with the peak night of the Perseids meteor shower, which lights up the sky each summer.
The PEOPLE Puzzler crossword is here! How quickly can you solve it? Play now!
The Perseids are especially famous for their brilliant fireballs. These exceptionally bright meteors burst with intense light and often linger longer than a typical shooting star.
NASA considers it 'the best meteor shower of the year,' producing 'swift, bright meteors that frequently leave long wakes of light and color.'
Read the original article on People
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

TMO Receives FDA Approval for Oncomine Dx Target Test
TMO Receives FDA Approval for Oncomine Dx Target Test

Yahoo

time20 minutes ago

  • Yahoo

TMO Receives FDA Approval for Oncomine Dx Target Test

Thermo Fisher Scientific TMO recently received approval from the Food and Drug Administration ('FDA') for its Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients who may be candidates for HERNEXEOS (zongertinib tablets), a tyrosine kinase inhibitor (TKI). The HERNEXEOS, developed by Boehringer Ingelheim, is the first and only FDA-approved orally administered targeted therapy for adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC). The recent approval is expected to bolster Thermo Fisher's Specialty Diagnostics arm. About TMO's Oncomine Dx Target Test The Oncomine Dx Target Test checks if NSCLC tumors harbor human epidermal growth factor receptor 2 (HER2/ERBB2) tyrosine kinase domain (TKD) activating mutations. It enables multi-biomarker analysis from a single tissue sample to aid treatment decisions in as little as four days. This reduces the need for second biopsies and avoids suboptimal therapy selection in the absence of a complete biomarker report. The test is fully reimbursed by Medicare, as well as by the top 20 commercial payers in the United States. Oncomine Dx Target Test's Global Approvals The Oncomine Dx Target Test received its first approval by the FDA as an NGS CDx in 2017, followed by regulatory approvals in 20 countries for 11 biomarkers and over 20 targeted therapies. The test is reimbursed by government and commercial insurers in the United States, Europe, Japan, South Korea and Israel, covering more than 550 million lives globally. In the United States alone, it is approved for targeted therapies in NSCLC, cholangiocarcinoma (CC), astrocytoma (AC) and oligodendroglioma (OG), anaplastic thyroid cancer (ATC), medullary thyroid cancer (MTC) and thyroid cancer (TC). Industry Prospects Favor TMO According to the American Cancer Society, lung cancer is the second most common cancer in both men and women in the United States, with NSCLC accounting for about 85-90% of all lung cancer cases. Research further indicates that roughly 2-4% of NSCLC patients carry a HER2 mutation. With lung cancer cases continuing to rise, the global market for NSCLC treatments is expected to expand significantly, reaching $66.04 billion by 2032 at a CAGR of 10.3% from 2024 to 2032 (per Fortune Business Insights). Another Development by TMO Thermo Fisher recently announced the FDA approval for Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for Dizal's ZEGFROVY (sunvozertinib) and in tumor profiling. Offerings by TMO's Competitors In the oncology space, Thermo Fisher faces competition from some prominent MedTech players. These companies are also making notable developments in their respective businesses. An expanding NGS oncology portfolio is helping Illumina ILMN drive the revolution in cancer genomics. The company's market-leading TruSight Oncology assay, TSO 500, continues to see increased utilization and broader adoption. In February, the company announced a new single-cell offering for CRISPR research with applications in oncology, immunology and drug target discovery. In 2024, the FDA approved its in vitro diagnostic (IVD) TSO Comprehensive test and its first two companion diagnostic (CDx) indications to rapidly match patients to targeted therapies. This year, Illumina is set to roll out TSO 500 v2, a new version that includes hundreds of genes across all variant classes and immuno-oncology biomarkers in a single assay from one sample, to facilitate therapy selection research. A rapidly expanding liquid biopsy and NGS-based testing portfolio is positioning Guardant Health GH as a leader in precision oncology. The company's flagship Guardant360 test has been recently enhanced with the Guardant Infinity platform, enabling a single blood draw to provide comprehensive tumor profiling, confirm the absence of actionable mutations and determine ER/PR/HER2 status. Regulatory milestones include approvals for Guardant360 CDx as a companion diagnostic in the United States, Japan and Singapore, covering multiple cancer targets such as EGFR and HER2 mutations. Its pipeline also includes the FDA-approved Shield blood test for colorectal cancer screening, offering a non-invasive alternative to colonoscopy. Exact Sciences' EXAS flagship screening product, the Cologuard test, is a non-invasive, stool-based DNA (sDNA) screening test that utilizes a multitarget approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company's precision oncology portfolio also offers the Oncotype DX Breast Recurrence Score test to identify patients who are most likely to benefit from chemotherapy, as well as those who may receive no clinical benefit from chemotherapy. Its Oncotype DX Colon Recurrence Score test is a multi-gene test for predicting recurrence risk in patients with stage II and stage III A/B colon cancer to enable an individualized approach to treatment planning. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report Illumina, Inc. (ILMN) : Free Stock Analysis Report Exact Sciences Corporation (EXAS) : Free Stock Analysis Report Guardant Health, Inc. (GH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Peeing In A Pool Is Gross, But Is It Really All That Bad? Here's What Science Says.
Peeing In A Pool Is Gross, But Is It Really All That Bad? Here's What Science Says.

Yahoo

timean hour ago

  • Yahoo

Peeing In A Pool Is Gross, But Is It Really All That Bad? Here's What Science Says.

You know you shouldn't pee in the pool, but you probably do it anyway. But at what cost? Do you even know? There are no hard-and-fast numbers on how often people pee in the pool, but at least one survey got 40% of American adults to admit to peeing in the pool. It doesn't seem like they're exaggerating: Older research published in the journal Environmental Science & Technology Letters analyzed water samples from 31 pools and hot tubs and discovered that a 220,000-gallon pool contained about 20 gallons of pee. Related: With that, the odds of you swimming in pee this summer are high. While peeing in the pool is gross, is it really all that bad? What can happen if you or someone around you does this just once? In the name of science, we tapped a toxicologist, infectious disease physician and microbiologist to break it all down. Related: What happens when you pee in a pool? A few things. The big issue is the interaction of urine with the chemicals in the pool. 'When human urine combines with chemicals that are present in chlorinated swimming pools, potentially harmful compounds called disinfection byproducts, or DBPs, can form,' said Dr. Kelly Johnson-Arbor, a toxicologist at MedStar Health. Urine naturally contains nitrogen-containing compounds like urea, ammonia and creatinine, Johnson-Arbor explained. 'These nitrogen-rich compounds can react with chlorine or other disinfectants found in swimming pools to form DBPs that can cause harmful health effects.' Chlorine specifically forms something called chloramines when it binds to human waste products (like pee) in the pool, according to the Centers for Disease Control and Prevention. These chloramines can build up in the water and off-gas into the air. This isn't just a urine thing. 'Chlorine interacts with many kinds of organic matter,' said Thomas Melendy, associate professor of microbiology and immunology, and biochemistry in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in New York. 'The reason it's put in pools is to act as an antibacterial and antiviral. It helps to keep the pool clean and noninfectious.' How big of a deal is it? It depends on how you look at it. 'From an infectious disease point of view, peeing in a well-chlorinated pool doesn't really present a problem. That's not to be confused with pooping in the pool, which does,' said Dr. Thomas Russo, professor and chief of infectious disease at the University at Buffalo. While urine isn't sterile, most people don't carry major pathogens in their pee that chlorine can't handle, Russo said. But chloramines can be an issue, according to Melendy. 'Any time chlorine interacts with organic matter, it makes chloramines,' he said. 'The more chloramines that are produced, the higher the risk of skin, eye and lung irritation.' (This can be a bigger problem in people with underlying respiratory issues such as asthma, he said.) Related: If ventilation in an area isn't great, chloramines that off-gas from the water will settle on the water's surface, where they can cause symptoms, according to the CDC. One of those chloramines is trichloramine, a volatile chemical that evaporates easily into the air and causes that signature 'chlorine' smell in swimming pools, Johnson-Arbor said. The more organic matter in the pool, the more chloramines are produced, Melendy said. (That includes pee, along with sweat and poop particles.) This also inactivates the chlorine, he points out. 'The more organic matter you introduce to the pool, the less effective chlorine is at being an antibacterial because it gets used up,' Melendy said. What if you pee in a saltwater pool? The impact is likely the same, Johnson-Arbor said. 'Saltwater pools use electrochemically generated chlorine instead of liquid chlorine for disinfection,' Johnson-Arbor said. (Electrochemically generated chlorine happens after an electric current is passed through a concentrated salt solution.) 'Since this process still generates chlorine, any nitrogen-containing matter that is present in a saltwater pool can still combine with the chlorine to generate DBPs,' Johnson-Arbor said. What if only one person pees in the pool? If you really have to go and there's no bathroom nearby, it's fair to wonder how much of an issue it will be if just one person pees in the pool. 'It's a matter of concentration,' Melendy said. 'There's so much chlorine and water in the pool. If just one person pees in a very large pool, it's unlikely to create a significant irritant.' (However, he points out that sensitivity varies from person to person.) Related: 'If it's one person in a really small pool, it might have a significant impact,' Melendy said. 'Conversely, if it's a big pool and a lot of people are doing it, it's going to produce lots of chloramine gases. This is a nuanced thing.' Johnson-Arbor also pointed out that this isn't just a urine issue. Sweat and poop particles inevitably slip off your skin and into the water, too. 'In addition, if individuals do not shower before entering pools, their loose hairs and skin cells can transfer from their bodies into the pool, further contributing to development of DBPs,' Johnson-Arbor said. Ultimately, doctors recommend taking a pass on peeing in the pool. 'Public health perspective aside, it's just bad behavior,' Russo said. Related... Doctors Are Getting Bombarded With 'Photo Dumps' Of Patients' Poop Pics — Here's Why Does Your Poop Sink? Here's What It Could Say About Your Health. So THAT'S Why You Always Need To Pee When You Get Close To Home

Is it Actually Fine to Look at Your Phone Before Bed?
Is it Actually Fine to Look at Your Phone Before Bed?

New York Times

timean hour ago

  • New York Times

Is it Actually Fine to Look at Your Phone Before Bed?

Don't look at your phone before bed if you want a decent night's sleep, we've been told. In fact, put it in another room! The blue light from screens will make it harder for you to conk out and leave you feeling less rested tomorrow, research says. Right? Actually, no. The link between blue light and sleep is murkier than originally thought, scientists now say. In some cases, screen use can even help you sleep. This doesn't mean you should turn on every device in your bedroom before you hit the sack. But there's already enough anxiety about how to sleep well; maybe don't stress about this. In a story published this morning, I explain what we know. The research After blue light hits your eyes, the brain suppresses the production of the hormone melatonin, which normally makes you feel drowsy. As a result, you feel more alert. Not all screen use seems to cause this dip. It may depend on how bright your device is, how long you use it for and how close it is to your eyes. One small study found that watching television from nine feet away had no effect on melatonin levels. And it's not even clear whether screen exposure impairs sleep in the first place. Most studies on the topic were performed in controlled laboratories with a small number of subjects, so it's hard to say if their results translate to regular life. What caused your restless night? Maybe it was an afternoon cup of coffee or a snoring bed partner, not blue light. In 2024, the National Sleep Foundation concluded that there wasn't enough evidence to blame blue light for sleeplessness. What you're watching Some research suggests that what you do with your device may matter more than whether you use it. Interactive activities like video games, social media, shopping and gambling are among the worst things you can do. They engage the brain's reward system, which can keep you awake and glued to your device well into the night. You can put down the iPad, but 'you can't turn your brain off,' one researcher told me. There's less consensus about other types of screen use. It may depend on what you're watching on your phone or reading on your Kindle. A suspenseful drama might mess with your sleep more than a comforting old series. If you already know the outcome, you'll have an easier time turning off your phone — and your brain. Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store